Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/5577
Title: | Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study | Authors: | Atallah, Natalie J Warren, Hailey M Roberts, Matthew B Elshaboury, Ramy H Bidell, Monique R Gandhi, Ronak G Adamsick, Meagan Ibrahim, Maryam K Sood, Rupali Bou Zein Eddine, Savo Cobler-Lichter, Matthew J Alexander, Natalie J Timmer, Kyle D Atallah, Christine J Viens, Adam L Panossian, Vahe S Scherer, Allison K Proctor, Teddie Smartt, Sherrie Letourneau, Alyssa R Paras, Molly L Johannes, Sascha Wiemer, Jan Mansour, Michael K |
Affiliations: | Faculty of Medicine | Issue Date: | 2022-01-13 | Publisher: | National Library of Medicine | Part of: | PLoS ONE | Volume: | 17 | Issue: | 1 | Abstract: | Coronavirus disease-2019 (COVID-19) is associated with a wide spectrum of clinical symptoms including acute respiratory failure. Biomarkers that can predict outcomes in patients with COVID-19 can assist with patient management. The aim of this study is to evaluate whether procalcitonin (PCT) can predict clinical outcome and bacterial superinfection in patients infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/5577 | DOI: | 10.1371/journal.pone.0262342 | Open URL: | Link to full text | Type: | Journal Article |
Appears in Collections: | Faculty of Medicine |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.